The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of oncology clinical pharmacist intervention on clinical trial enrollment in The U.S. Oncology Network’s MYLUNG Consortium.
 
Elizabeth Koselke
Employment - McKesson
Stock and Other Ownership Interests - McKesson
Speakers' Bureau - AstraZeneca/MedImmune; Jazz Pharmaceuticals; Rigel
 
Shannon Hough
Employment - McKesson
 
Josh Howell
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Stock and Other Ownership Interests - McKesson; Moderna Therapeutics; Oncolytics (I)
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
 
Marcus A. Neubauer
Leadership - McKesson
Travel, Accommodations, Expenses - McKesson
 
Susie A. Bullock
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Jennifer M. Walberg
Employment - US Oncology
 
Melissa Rammage
Patents, Royalties, Other Intellectual Property - Patent (publish) with IBM
 
James E. Butrynski
No Relationships to Disclose
 
David Hakimian
Consulting or Advisory Role - McKesson; TG Therapeutics
 
Robert M. Jotte
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - Mirati Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Michael W. Meshad
No Relationships to Disclose
 
Kashif Ali
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; US Oncology
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AZTherapies; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Fresenius Kabi; Janssen Oncology; Jazz Pharmaceuticals; Lilly; McGivney Global Advisors; Merck; Mirati Therapeutics; Pfizer; Sanofi; Sanofi/Regeneron; Seagen
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Robert L. Coleman
Employment - US Oncology
Leadership - Onxeo
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche; Genmab; Gradalis; Immunogen; Merck; Merck; Novocure; Oncolytics; OncoMed; OncXerna Therapeutics; Regeneron; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Amgen (Inst); Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Immunogen (Inst); Johnson & Johnson; Lilly (Inst); Merck; Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Makenzi Colleen Evangelist
Consulting or Advisory Role - AstraZeneca; Mirati Therapeutics; Regeneron; Takeda